For research teamsHelp me find a study
Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 9,181-9,192 of 10,592
Drug study icon
CompletedNCT01994473

Safety study of SEP-363856 in schizophrenia

This study is completed in the United States. It is testing SEP-363856 for schizophrenia.

In United States
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 55 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
View study
Behavioral study icon
CompletedNCT01869374

Study Comparing Magnetic Seizure Therapy (MST) to Electroconvulsive Therapy (ECT) for Depression in Older Adults

This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

In United States
Depression, BipolarityBehavioralFrom 55 Years to 90 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Depression, Bipolarity
View study
Drug study icon
CompletedNCT00134459

Study Evaluating Bifeprunox in Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Condition
Bipolarity, Depression
View study
Drug study icon
TerminatedNCT00366327

Study Evaluating Bifeprunox in people with Schizophrenia.

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaDrugFrom 18 Years to 66 Years
Countries
United States
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Condition
Schizophrenia
View study
Drug study icon
CompletedNCT00488618

Study Evaluating Cariprazine (RGH-188) in the Treatment of people with Acute Mania

This study exists to understand how the medication RGH-188 holds up over time after the earliest research stage. Researchers are trying to understand how people respond to the medication RGH-188 in practice and what may need to be adjusted.

In United States
BipolarityDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Forest Laboratories
Condition
Bipolarity
View study
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.